Literature DB >> 29364429

New perspectives for the treatment of Hansen's disease.

Sinésio Talhari1, Bernardo Gontijo2, Everton Carlos Siviero do Vale2, Silvio Alencar Marques2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29364429      PMCID： PMC5786387          DOI： 10.1590/abd1806-4841.2017920601

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN： 0365-0596            Impact factor:   1.896


× No keyword cloud information.
  4 in total

1.  Reflections on the elimination of leprosy.

Authors:  P E Fine
Journal:  Int J Lepr Other Mycobact Dis       Date:  1992-03

2.  Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index.

Authors:  Maria Lucia Fernandes Penna; Samira Bűhrer-Sékula; Maria Araci de Andrade Pontes; Rossilene Cruz; Heitor de SáOliveira Gonçalves; Gerson Oliveira Penna
Journal:  Lepr Rev       Date:  2014-12       Impact factor: 0.537

3.  Hansen's disease: a vanishing disease?

Authors:  Sinésio Talhari; Maria Aparecida de Faria Grossi; Maria Leide W D R de Oliveira; Bernardo Gontijo; Carolina Talhari; Gerson Oliveira Penna
Journal:  Mem Inst Oswaldo Cruz       Date:  2012-12       Impact factor: 2.743

4.  Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.

Authors:  Gerson Oliveira Penna; Samira Bührer-Sékula; Lígia Regina Sansigolo Kerr; Mariane Martins de Araújo Stefani; Laura Cunha Rodrigues; Marcelo Grossi de Araújo; Andrea Machado Coelho Ramos; Ana Regina Coelho de Andrade; Maurício Barcelos Costa; Patricia Sammarco Rosa; Heitor de Sá Gonçalves; Rossilene Cruz; Maurício Lima Barreto; Maria Araci de Andrade Pontes; Maria Lúcia Fernandes Penna
Journal:  PLoS Negl Trop Dis       Date:  2017-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.